Clovis Oncology Inc (OTC Pink - Limited Information:CLVSQ)
| 0.03 Delayed Data As of Jun 06 |  +0.0019 / +6.76%Today’s Change | 0.01 Today|||52-Week Range 3.25 | -43.13% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Gross Paul Edward Corporate Officer |  Sale | 8/02/2022 | 2,638 | $1.46 | $3.9K | -98.12% |
Muehl Daniel W Corporate Officer | Sale | 8/02/2022 | 2,554 | $1.46 | $3.7K | -98.12% |
Rolfe Lindsey Corporate Officer | Sale | 8/02/2022 | 2,391 | $1.46 | $3.5K | -98.12% |
Gross Paul Edward Corporate Officer | Sale | 8/02/2022 | 2,169 | $1.46 | $3.2K | -98.12% |
Ivers Read Gillian C Corporate Officer | Sale | 8/02/2022 | 2,100 | $1.46 | $3.1K | -98.12% |
Muehl Daniel W Corporate Officer | Sale | 8/02/2022 | 2,100 | $1.46 | $3.1K | -98.12% |
Rolfe Lindsey Corporate Officer | Sale | 9/02/2022 | 2,545 | $1.20 | $3.1K | -97.35% |
Rolfe Lindsey Corporate Officer | Sale | 8/02/2022 | 1,939 | $1.46 | $2.8K | -98.12% |
Gross Paul Edward Corporate Officer | Sale | 9/02/2022 | 2,308 | $1.20 | $2.8K | -97.35% |
Muehl Daniel W Corporate Officer | Sale | 9/02/2022 | 2,234 | $1.20 | $2.7K | -97.35% |
Page of 6